Literature DB >> 21999222

Otomycosis in Shanghai: aetiology, clinical features and therapy.

Xianhao Jia1, Qin Liang, Fanglu Chi, Wenjun Cao.   

Abstract

Otomycosis is frequently seen in Shanghai and is a challenging problem due to recurrence and resistance to therapy. The aims of this study were to determine the pattern of fungal agents, sex distribution, clinical presentation, predisposing factors, complications and treatment outcomes of otomycosis. Retrospective review of 108 patients with a clinical diagnosis of otomycosis treated from September 2009 to September 2010 in otolaryngology outpatient department. It has been found to be more prevalent in female patients than male patients with a sex ratio (F : M) of 2 : 1. Aspergillus niger (54.78%) followed by Candida albicans (16.52%) were the dominant fungi. Pruritus and otorrhea were the most common presenting complaints. The predisposing factors included frequent scratching of the external ear canal (79.63%), taking ototopical and/or oral antimicrobials (24.07%), diabetes (11.11%) and otologic procedures (7.41%). Residual disease was observed in 9.26% and recurrence in 8.89% of the subjects. Topical Fluconazole ear drops and mechanical debridement of visible fungal elements in the external auditory canal were all relatively effective with 83.33% resolution rate on initial application. The diagnosis of otomycosis requires vigilance from clinicians given its non-specific symptoms. Sometimes mycological examinations are necessary. Treatment regimens such as topical fluconazole coupled with mechanical debridement are generally effective. However, recurrence is not uncommon and eradication of disease can be particularly difficult in patients with diabetes and a mastoid cavity.
© 2011 Blackwell Verlag GmbH.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21999222     DOI: 10.1111/j.1439-0507.2011.02132.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  21 in total

Review 1.  Otomycosis in iran: a review.

Authors:  Maral Gharaghani; Zahra Seifi; Ali Zarei Mahmoudabadi
Journal:  Mycopathologia       Date:  2015-01-30       Impact factor: 2.574

2.  Molecular Identification and Antifungal Susceptibility of Yeasts and Molds Isolated from Patients with Otomycosis.

Authors:  Keyvan Kiakojuri; Saeid Mahdavi Omran; Somayeh Roodgari; Mojtaba Taghizadeh Armaki; Mohammad Taghi Hedayati; Tahereh Shokohi; Iman Haghani; Javad Javidnia; Firoozeh Kermani; Hamid Badali; Mahdi Abastabar
Journal:  Mycopathologia       Date:  2021-03-15       Impact factor: 2.574

3.  Type of Antifungals: Does it Matter in Empirical Treatment of Otomycosis?

Authors:  Nagendran Navaneethan; Raj Prakash Dharmapuri YaadhavaKrishnan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-10-04

4.  Otomycosis in Jos: Predisposing factors and Management.

Authors:  A S Adoga; A A Iduh
Journal:  Afr J Med Med Sci       Date:  2014-09

Review 5.  Otomycosis in the South of Iran with a High Prevalence of Tympanic Membrane Perforation: A Hospital-Based Study.

Authors:  Javad Javidnia; Zahra Ghotbi; Aynaz Ghojoghi; Kavous Solhjoo; Mohamed Mahdi Alshahni; Seyed Ali Jeddi; Bahram Ahmadi; Sadegh Nouripour-Sisakht; Saham Ansari; Gholamreza Shokoohi
Journal:  Mycopathologia       Date:  2022-03-26       Impact factor: 2.574

6.  Otomycosis with Perforated Tympanic Membrane: Self medication with Topical Antifungal Solution versus Medicated Ear Wick.

Authors:  A S Abou-Halawa; M A Khan; A A Alrobaee; A A Alzolibani; H A Alshobaili
Journal:  Int J Health Sci (Qassim)       Date:  2012-01

7.  Otomycosis in Adolescent Patients Referred to the Therapeutic Centers in Babol City, Iran.

Authors:  Keivan Kiakojuri; Ramazan Rajabnia; Bahareh Jalili; Soraya Khafri; Saeid Mahdavi Omran
Journal:  Jundishapur J Microbiol       Date:  2015-05-31       Impact factor: 0.747

8.  Effectiveness of 7.5 percent povidone iodine in comparison to 1 percent clotrimazole with lignocaine in the treatment of otomycosis.

Authors:  Ajay Philip; Regi Thomas; Anand Job; V Rajan Sundaresan; Shalini Anandan; Rita Ruby Albert
Journal:  ISRN Otolaryngol       Date:  2013-07-25

9.  Primary otomycosis in the Indian subcontinent: predisposing factors, microbiology, and classification.

Authors:  Sampath Chandra Prasad; Subbannayya Kotigadde; Manisha Shekhar; Nikhil Dinaker Thada; Prashanth Prabhu; Tina D' Souza; Kishore Chandra Prasad
Journal:  Int J Microbiol       Date:  2014-05-18

10.  Assessment of Response to Treatment in Patients with Otomycosis.

Authors:  Keyvan Kiakojori; Nasim Bagherpour Jamnani; Soraya Khafri; Saeid Mahdavi Omran
Journal:  Iran J Otorhinolaryngol       Date:  2018-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.